Pharming Group

+$0.26 (+2.75%) As of 7:25 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharming Group and other ETFs, options, and stocks.

About PHAR

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema.

CEO

Sijmen de Vries

Employees

—

Headquarters

Leiden, Zuid-Holland

Founded

1988

PHAR Key Statistics

Market Cap

631.72M

Price-Earnings Ratio

35.55

Dividend Yield

—

Average Volume

1.69K

High Today

$9.70

Low Today

$9.70

Open Price

$9.70

Volume

846.00

52 Week High

$21.99

52 Week Low

$9.02

PHAR Earnings

$0.00

$0.01

$0.02

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 25, Pre-Market

Why Robinhood?

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. View more

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema.